Header Logo

Connection

Sudhir Agrawal to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications Sudhir Agrawal has written about Clinical Trials as Topic.
Sudhir Agrawal
Connection Strength
0.100
Clinical Trials as Topic
  1. Agrawal S, Kandimalla ER. Role of Toll-like receptors in antisense and siRNA [corrected]. Nat Biotechnol. 2004 Dec; 22(12):1533-7.
    View in: PubMed
    Score: 0.048
  2. Agrawal S, Kandimalla ER. Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol Med. 2002 Mar; 8(3):114-21.
    View in: PubMed
    Score: 0.040
  3. Lacasse EC, Kandimalla ER, Winocour P, Sullivan T, Agrawal S, Gillard JW, Durkin J. Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640. Ann N Y Acad Sci. 2005 Nov; 1058:215-34.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.